Joltoo
Grants
Browse catalogTailored listsFind your matchesFundersPrograms
InvestorsAdvisoryInsights
DeepTech 2026 PlaybookRequest access
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Épimède
É

Épimède

DeepTech NativeLiège, BelgiumActiveWebsite
Stage FocusSeries A, Series B+
GeographyEurope
TypeVC
Last Activity-
Industry Focus
Industries
BiotechMedtechPhotonicsClimate TechAI
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Épimède is a Belgian regulated closed-end investment fund (PRICAF privée) based in Liège, operating since 2003 and backed by investors including Ethias, Integrale, Noshaq, the Belgian federal holding company SFPI-FPIM, and BNP Paribas Fortis Private Equity. It invests €1M to €7M per deal into unlisted Belgian companies, with a strong preference for businesses headquartered in Wallonia, across life...

Notable Investments
D
Diagenode
A
ASIT Biotech
N
NOVADIP Biosciences
N
Ncardia
W
Wishbone
E
Endo Tools Therapeutics
I
Imcyse
L
Lasea
R
Radiomics

Similar Funds

HV

Hummingbird VC

London, United Kingdom

GeneralistBiotechAIBlockchainPre-SeedSeed
M Ventures (Merck)

M Ventures (Merck)

Amsterdam, Netherlands

DeepTech NativeBiotechSemiconductorsAdvanced MaterialsSeedSeries A
RT

Rising Tide

Pacifica, California, United States

DeepTech NativeBiotechMedtechSpacePre-SeedSeed
Ahren Innovation Capital

Ahren Innovation Capital

London, United Kingdom

DeepTech NativeBiotechRoboticsClimate TechSeedSeries A
Cambridge Innovation Capital

Cambridge Innovation Capital

Cambridge, United Kingdom

Pure DeepTechBiotechQuantumSemiconductorsSeedSeries A
ED

Emerald Development Managers

United States

DeepTech NativeBiotechCybersecurityAdvanced MaterialsSeedSeries A
Work at Épimède? Claim this page
Joltoo
PricingInsightsTailored lists
Privacy PolicyTerms of Service
Security
© 2026 Joltoo. All rights reserved.